Reserve your spot for this national forum for late-stage private and emerging companies. What to expect:
-
More than 190 late-stage private & emerging public company presentations
-
Therapeutic panels led by clinical thought leaders
-
Business roundtables addressing key issues affecting biotech executives
-
Tech Transfer panel and networking session
-
Plenary Sessions: Capital Access 201 and The Return to a Thriving Biotech Marketplace - What's It Going To Take
-
Partnering meetings
-
Networking opportunities investors and industry executives focused exclusively on biotechnology
Go to http://investorforum.bio.org for more info and to register.